CD8A and neoplasm: Studies have confirmed the possible inhibition of the anti-tumor response of the immune system by epithelial-mesenchymal transition (EMT)- related gene expression in lung cancer and liver cancer patients through the inhibition of CD8+ cytotoxic T-cell proliferation [10,11].